Oct
2026
Fiera Milano, Italy
Visit us
stand 12F7, Contract Manufacturing & Services

Lupin Limited

Exhibitor at CPHI Milan 2026
About Us

Lupin is an innovation led transnational pharmaceutical company with presence in over 100 countries and turnover of US $ 3 billion. We focus on development of difficult to develop, specialty and niche generics in the fields of CNS, anti-infectives, respiratory, CVS, urology, pain and diabetes.  With continued investments towards internalizing technology platforms in the fields of biotechnology, complex/long acting injectables, inhalation, Lupin is well positioned to become a global pharmaceutical powerhouse with a broad specialty portfolio. 

  • Country/Region:
    India
  • On CPHI since:
    2019
  • Certificates:
    4
  • Employees:
    5000+
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)
Contact info
  • 4th Floor Kalpataru Inspire, Oppo. Grand Hyatt Hotel, Santacruz, 400055, Mumbai, India, India
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 12F7, Contract Manufacturing & Services

Lupin Limited Resources (1)

  • Brochure HPAPI CDMO Services

    At Lupin Manufacturing Solutions (LMS), we enable global pharmaceutical innovators to bring oncology therapies to market faster, safer and compliant. With deep scientific expertise, advanced containment infrastructure, and phase-appropriate manufacturing flexibility, we serve as an end-to-end CDMO partner for the development and production of highly potent oncology APIs and intermediates. Backed by the global legacy of Lupin Limited, our oncology operations combine scientific rigor, regulatory excellence, and scalable manufacturing from lab to commercial scale.